INTERNATIONAL PATENT: THE PENN STATE RESEARCH FOUNDATION FILES APPLICATION FOR "IMPROVING IMMUNE CELL-BASED THERAPIES AGAINST SOLID TUMORS WITH OPTOGENETICALLY ENGINEERED SEPTIN PROTEINS"

GENEVA, Jan. 28 -- THE PENN STATE RESEARCH FOUNDATION (304 Old MainUniversity Park, PA 16802) filed a patent application (PCT/US2024/038351) for "IMPROVING IMMUNE CELL-BASED THERAPIES AGAINST SOLID TUMORS WITH OPTOGENETICALLY ENGINEERED SEPTIN PROTEINS" on Jul 17, 2024. With publication no. WO/2025/019568, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DOKHOLYAN, Nikolay, V. (1023 Fairdell DriveHummelstown, PA 17036), CHEN, Jiaxing (2302 Rudy RoadHarrisburg, PA 17104)

Abstract: A method for enhancing immune cell penet...